Exploring the Cancer Treatment Reimbursement Journey in Canada скачать в хорошем качестве

Exploring the Cancer Treatment Reimbursement Journey in Canada

This session will provide participants with an overview of what is involved in getting a new cancer treatment reviewed and approved in Canada. The webinar will feature representatives from 3Sixty Public Affairs, who will detail the key steps required to provide patient access to a new treatment option. The journey begins with a Health Canada review of safety, efficacy and quality. That is followed by comparative cost and effectiveness evaluations and the establishmentof a place in therapy by health technology assessment (HTA) agencies. After the HTA recommendations are issued, then the national pricing negotiation process takes place, followed by reimbursement decision-making at the jurisdictional level. During all that, new products also must pass through a national price review. Patients and stakeholders have some opportunities to provide input at various points in the process. All that and more will be covered during the presentation. Afterward, the presenters will lead an interactive question and answer session that will permit audience members to explore these processes further. View the slides here: https://www.slideshare.net/jackiemant... About the Presenters: As CEO of 3Sixty Public Affairs, Bill Dempster implements high-impact health policy, government relations and business strategies for clients in the health and life sciences sector. For over twenty years, Bill has drawn on deep business, legal and government experience to help clients find mutually beneficial solutions to complex regulatory, reimbursement and policy problems. Bill previously worked for Pfizer Canada, a Member of Parliament, the United Nations and major Canadian law firms. He is fluently bilingual and has degrees in history (King’s College, University of Western Ontario), law (Queen’s University), and a Masters of Arts in international affairs (Norman Paterson School of International Affairs, Carleton University). Bill was called to the Bar of Ontario in 2002. Gerry Jeffcott is a Senior Associate with more than 30 years’ experience addressing a broad range of health and pharmaceutical policy issues at the national, federal and provincial levels. He is a recognized expert and commentator on market access and reimbursement issues, having been a mentor, trainer and reporter at different times. He is also a facilitator and coalition-builder, playing key roles in helping groups of pharmaceutical companies address specific policy issues in the oncology and rare disease environments. He is the co-author of two Council for Continuing Pharmaceutical Education courses — Pharmaceutical Market Access in Canada and Health Care in Canada – and he contributes regularly to IQVIA’s strategic information publications, including the Provincial Reimbursement Advisor and PharmaFocus. Follow CCSN on social media: Twitter -   / survivornetca   Facebook -   / canadiansurvivornet   Instagram:   / survivornet_ca   Pinterest -   / survivornetwork